ENDODIAGNOSIS
making endosure, The only tier 1 test for endometriosis, accessibleENDOSURE TEST has closed the 8.6-year diagnostic gap for an endometriosis diagnosis to minutes. Now available in Canadian clinics.
- Non-invasive & painless
- 30-minute test provides near-instant results
- High Accuracy: 99%+ (98% for those 36 years and older)
- Detects disease at all stages
- Appropriate for all ages: pre-menarche to post-menopause
- Results offer decision support for your clinician so a diagnosis, and treatment, can start sooner
How does it Work?
In under an hour, ENDOSURE test results support your clinician’s decisions
Fighting for Faster Diagnosis
Despite growing awareness of the condition, many women wait years to be diagnosed with endometriosis. We will change that.
After Diagnosis - What's next?
Diagnosis expedites the path to treatment, symptom management and stopping future disease progression.
empowering clinicians
Transforming patient’s lives
Why does it take Canadians ~5 years to receive an endometriosis diagnosis? With laparoscopic surgery as the gold standard for diagnosis, it’s no surprise there’s a long wait for surgery while serious symptoms like pain and infertility continue.
Now tier 1 endometriosis testing is available. Non-invasive and painless, with a patient experience more like an electrocardiogram (ECG). For clinicians, ENDOSURE testing provides decision support when endometriosis is suspected, facilitating a diagnosis of endometriosis—at any disease stage and for any patient age.
ENDOSURE is authorized for sale by Health Canada.
Why ENDOSURE? It’s tier 1 testing.
- Non-Invasive: No surgery required
- Rapid Results: Leave with your results. Bring them to your healthcare provider.
- Highly Accurate: 99% accuracy (98% for those 36 years and older)
- All Stages: Detects endometriosis at any stage
- All Ages: Appropriate for any age of patient, from pre-menarche to post-menopause
Rapid Non-invasive diagnosis and staging in one visit
The Science
With testing more like an ECG, Tier 1 diagnostic testing for endometriosis is now fast, easy, safe and accurate
The ENDOSURE Test collects objective data with electroviscerography (EVG), then looks for a characteristic “fingerprint” of intestinal seizure activity that only occurs in the presence of endometriosis. It’s called the “GIMA biomarker,” a gastrointestinal myoelectric activity profile unique to endometriosis sufferers.
The raised intestinal seizure activity results from increased prostaglandins secreted by endometrial tissue, regardless of location.
Normal ranges of contractions are 1-12 cycles per minute (CPM). With endometriosis present, uncontrolled high-frequency contractions range from 15-200 CPM. This causes many painful symptoms.
It also creates a characteristic “fingerprint” of electrical contraction activity that can be measured objectively. Endosure™ is a non-invasive diagnostic test that uses pads on the abdomen to non-actively collect electrical signals and compares them with the GIMA biomarker for endometriosis. It provides an almost instant determination of whether a patient displays this familiar fingerprint of endometriosis activity.
closing the 5 year diagnositic gap
the Endometriosis diagnosis dilemma
Endometriosis affects 7% of women in Canada who face an average 5.4-year diagnostic delay.1 That’s 65 painful periods before getting diagnosis.
Diagnostic delays
The need for laparoscopy, the current gold standard for diagnosis, contributes to delays between onset of symptoms and diagnosis of endometriosis.
It was never in your head. It was in your gut.
Endometriosis can be a debilitating condition, presenting a variety of symptoms such as pelvic pain and infertility that affects quality of life. Until now rapid diagnostic testing that supported timely diagnosis and treatment was unavailable.
Now we can test for it.
Endosure™ determines if you have the GIMA biomarker or not. This diagnostic test provides clinicians with decision support so they can rapidly confirm endometriosis as the cause of menstrual or abdominal pain and infertility. This helps women receive care much earlier.
About Endometriosis
Endometriosis is an estrogen-dependent, frequently chronic inflammatory disease often associated with pelvic and abdominal pain, bloating, painful irregular bowel or urinary symptoms, and infertility. Diagnosis is difficult because symptoms overlap with other conditions, pain may become viewed as normal by the patient or treating clinicians, and there are limitations with current standard diagnostic testing for early disease. Symptomatic endometriosis has an estimated population prevalence of at least 10% globally, with most experiencing significant diagnostic delays of 3 to 11 years from onset of symptoms.2
A recent Canadian study reported a 7% population incidence with a 5.4 year diagnostic gap.1
Data of at-risk populations shows that 45% of adolescents and 55% of early adults have underlying endometriosis as the cause for regular dysmenorrhea.3
Years waiting for diagnosis
Diagnostic delays are 3 to 11 years, with an average of 8.6 years from time of presentation until diagnosis.
Women with endometriosis globally
Endometriosis affects roughly 10% (190 million) of reproductive age women and girls globally who can suffer from constant and intense pelvic pain, fatigue, depression, anxiety, and infertility.2
%
Suffer Pain Full Periods (Dysmenorrhea)
Up to 80% of women with dysmenorrhea have endometriosis. Needing a laparoscopy for diagnosis leads to years long waits that allows the disease to progress until pain levels warrant surgical risk.
%
Up to 90% of women with "unexplained infertility" have endometriosis
15% of endometriosis patients have no pain but struggle with infertility. Research shows endometriosis is the root cause of up to 90% of those with “unexplained infertility”.
Limited Appointments ARE available.
Book your Test.
Research
- Singh, S., et al; Prevalence, Symptomatic Burden, and Diagnosis of Endometriosis in Canada: Cross-Sectional Survey of 30000 Women, Journal of Obstetrics and Gynaecology Canada, Volume 42, Issue 7, 829 – 838
- World Health Organization. Endometriosis. Published March 24, 2023. Accessed November 25, 2024. https://www.who.int/news-room/fact-sheets/detail/endometriosis
- Nnoaham, Kelechi E. et al., Impact of endometriosis on quality of life and work productivity: a multicenter study across ten countries, Fertility and Sterility, Volume 96, Issue 2, 366 – 373.e8